Mohan Jitendra - 18 May 2026 Form 4 Insider Report for Astera Labs, Inc. (ALAB)

Reporting relationship
Chief Executive Officer, Director
Issuer ticker
ALAB
Reported as of
18 May 2026
Net transaction value
-$31,295,012
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
20 May 2026, 19:09:58 UTC
Prior SEC filing
11 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Philip Mazzara, Attorney-in-Fact

Key filing fact

Mohan Jitendra filed Form 4 for Astera Labs, Inc. (ALAB) on 20 May 2026.

Key facts

  • This page summarizes Mohan Jitendra's Form 4 filing for Astera Labs, Inc. (ALAB).
  • 22 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 20 May 2026, 19:09.

Change

  • Previous filing in this sequence was filed on 11 May 2026.
  • Current net transaction value: -$31,295,012.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001998053 Primary reporting owner

Mohan Jitendra

Relationship
Chief Executive Officer, Director
Address
C/O ASTERA LABS, INC., 2345 NORTH FIRST STREET, SAN JOSE
Signature
/s/ Philip Mazzara, Attorney-in-Fact
Signature date
20 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALAB transaction

Common Stock

Sale

Transaction value
$420,503
Shares
-1,996
Change %
-0.05%
Price
$210.67
Shares after
3,927,187
Date
18 May 2026
Ownership
By Living Trust
Footnotes
F1, F2, F3
ALAB transaction

Common Stock

Sale

Transaction value
$1,116,204
Shares
-5,277
Change %
-0.13%
Price
$211.52
Shares after
3,921,910
Date
18 May 2026
Ownership
By Living Trust
Footnotes
F1, F3, F4
ALAB transaction

Common Stock

Sale

Transaction value
$2,227,155
Shares
-10,474
Change %
-0.27%
Price
$212.64
Shares after
3,911,436
Date
18 May 2026
Ownership
By Living Trust
Footnotes
F1, F3, F5
ALAB transaction

Common Stock

Sale

Transaction value
$3,079,631
Shares
-14,416
Change %
-0.37%
Price
$213.63
Shares after
3,897,020
Date
18 May 2026
Ownership
By Living Trust
Footnotes
F1, F3, F6
ALAB transaction

Common Stock

Sale

Transaction value
$4,023,976
Shares
-18,749
Change %
-0.48%
Price
$214.62
Shares after
3,878,271
Date
18 May 2026
Ownership
By Living Trust
Footnotes
F1, F3, F7
ALAB transaction

Common Stock

Sale

Transaction value
$4,687,318
Shares
-21,739
Change %
-0.56%
Price
$215.62
Shares after
3,856,532
Date
18 May 2026
Ownership
By Living Trust
Footnotes
F1, F3, F8
ALAB transaction

Common Stock

Sale

Transaction value
$2,235,396
Shares
-10,324
Change %
-0.27%
Price
$216.52
Shares after
3,846,208
Date
18 May 2026
Ownership
By Living Trust
Footnotes
F1, F3, F9
ALAB transaction

Common Stock

Sale

Transaction value
$1,131,952
Shares
-5,200
Change %
-0.14%
Price
$217.68
Shares after
3,841,008
Date
18 May 2026
Ownership
By Living Trust
Footnotes
F1, F3, F10
ALAB transaction

Common Stock

Sale

Transaction value
$709,758
Shares
-3,247
Change %
-0.08%
Price
$218.59
Shares after
3,837,761
Date
18 May 2026
Ownership
By Living Trust
Footnotes
F1, F3, F11
ALAB transaction

Common Stock

Sale

Transaction value
$391,313
Shares
-1,782
Change %
-0.05%
Price
$219.59
Shares after
3,835,979
Date
18 May 2026
Ownership
By Living Trust
Footnotes
F1, F3, F12
ALAB transaction

Common Stock

Sale

Transaction value
$520,141
Shares
-2,356
Change %
-0.06%
Price
$220.77
Shares after
3,833,623
Date
18 May 2026
Ownership
By Living Trust
Footnotes
F1, F3, F13
ALAB transaction

Common Stock

Sale

Transaction value
$257,168
Shares
-1,158
Change %
-0.03%
Price
$222.08
Shares after
3,832,465
Date
18 May 2026
Ownership
By Living Trust
Footnotes
F1, F3, F14
ALAB transaction

Common Stock

Sale

Transaction value
$530,473
Shares
-2,375
Change %
-0.06%
Price
$223.36
Shares after
3,830,090
Date
18 May 2026
Ownership
By Living Trust
Footnotes
F1, F3, F15
ALAB transaction

Common Stock

Sale

Transaction value
$94,781
Shares
-423
Change %
-0.01%
Price
$224.07
Shares after
3,829,667
Date
18 May 2026
Ownership
By Living Trust
Footnotes
F1, F3, F16
ALAB transaction

Common Stock

Sale

Transaction value
$541,026
Shares
-2,400
Change %
-0.06%
Price
$225.43
Shares after
3,827,267
Date
18 May 2026
Ownership
By Living Trust
Footnotes
F1, F3, F17
ALAB transaction

Common Stock

Sale

Transaction value
$249,406
Shares
-1,100
Change %
-0.03%
Price
$226.73
Shares after
3,826,167
Date
18 May 2026
Ownership
By Living Trust
Footnotes
F1, F3, F18
ALAB transaction

Common Stock

Sale

Transaction value
$425,901
Shares
-1,848
Change %
-0.05%
Price
$230.47
Shares after
3,824,319
Date
18 May 2026
Ownership
By Living Trust
Footnotes
F1, F3, F19
ALAB transaction

Common Stock

Sale

Transaction value
$537,624
Shares
-2,320
Change %
-0.06%
Price
$231.73
Shares after
3,821,999
Date
18 May 2026
Ownership
By Living Trust
Footnotes
F1, F3, F20
ALAB transaction

Common Stock

Sale

Transaction value
$662,037
Shares
-2,841
Change %
-0.07%
Price
$233.03
Shares after
3,819,158
Date
18 May 2026
Ownership
By Living Trust
Footnotes
F1, F3, F21
ALAB transaction

Common Stock

Sale

Transaction value
$279,843
Shares
-1,189
Change %
-0.03%
Price
$235.36
Shares after
3,817,969
Date
18 May 2026
Ownership
By Living Trust
Footnotes
F1, F3
ALAB transaction

Common Stock

Sale

Transaction value
$6,973,408
Shares
-27,937
Change %
-0.73%
Price
$249.61
Shares after
3,790,032
Date
19 May 2026
Ownership
By Living Trust
Footnotes
F1, F3, F22
ALAB transaction

Common Stock

Sale

Transaction value
$200,000
Shares
-800
Change %
-0.02%
Price
$250.00
Shares after
3,789,232
Date
19 May 2026
Ownership
By Living Trust
Footnotes
F1, F3, F23
ALAB holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
699,999
Date
18 May 2026
Ownership
By Trust
Footnotes
F24
ALAB holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
700,000
Date
18 May 2026
Ownership
By 2021 Trust 1
Footnotes
F25
ALAB holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
700,000
Date
18 May 2026
Ownership
By 2021 Trust 2
Footnotes
F26
ALAB holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
450,001
Date
18 May 2026
Ownership
By 2022 Trust 1
Footnotes
F27
ALAB holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
450,001
Date
18 May 2026
Ownership
By 2022 Trust 2
Footnotes
F28
ALAB holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,452,739
Date
18 May 2026
Ownership
Direct
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 28 footnotes

Footnote F1

The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025.

Footnote F2

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $210.0564 to $211.0346, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Footnote F4

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $211.0800 to $212.0525, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F5

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $212.0959 to $213.0900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F6

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $213.1000 to $214.0988, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F7

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $214.1000 to $215.0843, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F8

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $215.1100 to $216.1035, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F9

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $216.1100 to $217.1000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F10

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $217.1100 to $218.0900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F11

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $218.1315 to $219.1300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F12

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $219.1400 to $220.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F13

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $220.1957 to $221.0300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F14

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $221.5000 to $222.4600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F15

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $222.5388 to $223.5300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F16

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $223.9000 to $224.1208, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F17

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $225.0600 to $226.0300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F18

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $226.2700 to $227.0600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F19

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $230.1600 to $230.9900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F20

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $231.1800 to $232.1506, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F21

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $232.5600 to $233.1700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F22

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $249.0000 to $249.9900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F23

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $250.0000 to $250.0100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F24

These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Footnote F25

These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Footnote F26

These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Footnote F27

These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Footnote F28

These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .